Form D · Biotechnology
RespireDx, Inc.
Highland, MD · CIK 0001791882
Offering snapshot reported Oct 25, 2019 · SEC filing
- Reported sold
- $700K Offering amount: $1.7M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 25, 2019 | Initial | $699,998 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-351857
Source: Form D, filed Oct 25, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Barry Mersky | Director, Executive |
| Michael Thomas | Director |
| Nick Van Terheyden | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
13001 Wainwright Road
Highland, MD, 20777
Highland, MD, 20777